Jun Shi

1.9k total citations
53 papers, 1.5k citations indexed

About

Jun Shi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jun Shi has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Jun Shi's work include Cancer-related molecular mechanisms research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Coagulation and Flocculation Studies (4 papers). Jun Shi is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Coagulation and Flocculation Studies (4 papers). Jun Shi collaborates with scholars based in China, United States and Singapore. Jun Shi's co-authors include Chin-Chun Lu, Yimin Zou, Jiangya Ma, Kun Fu, Adam M. Schmitt, Leslie A. King, Xue Fu, Liyan Jiang, Anna I Lyuksyutova and Xue‐Jun Song and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jun Shi

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Shi China 19 473 335 273 124 120 53 1.5k
Guoyu Zhou China 28 659 1.4× 65 0.2× 437 1.6× 193 1.6× 163 1.4× 137 2.5k
Xu Li China 24 446 0.9× 222 0.7× 101 0.4× 124 1.0× 26 0.2× 91 1.8k
Ronghui Li China 24 1.0k 2.1× 121 0.4× 125 0.5× 176 1.4× 67 0.6× 94 2.0k
Peter G. Miller United States 20 488 1.0× 183 0.5× 57 0.2× 179 1.4× 38 0.3× 41 1.5k
Wenxiang Wang China 28 602 1.3× 54 0.2× 42 0.2× 165 1.3× 60 0.5× 117 2.1k
Jufang Huang China 26 1.1k 2.3× 146 0.4× 44 0.2× 93 0.8× 62 0.5× 129 2.0k
Linyi Chen Taiwan 30 1.4k 3.0× 373 1.1× 58 0.2× 273 2.2× 78 0.7× 100 2.8k
Xue Wu China 28 481 1.0× 19 0.1× 192 0.7× 67 0.5× 52 0.4× 70 2.0k
Dandan Hu China 26 334 0.7× 54 0.2× 47 0.2× 228 1.8× 10 0.1× 148 2.1k
Haitao Zhu China 20 972 2.1× 76 0.2× 115 0.4× 195 1.6× 34 0.3× 60 2.0k

Countries citing papers authored by Jun Shi

Since Specialization
Citations

This map shows the geographic impact of Jun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Shi more than expected).

Fields of papers citing papers by Jun Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Shi. The network helps show where Jun Shi may publish in the future.

Co-authorship network of co-authors of Jun Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Shi. A scholar is included among the top collaborators of Jun Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Shi. Jun Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Wen‐Dong, Wenhao Wu, Zhoulyu Rao, et al.. (2025). Targeted melanoma therapy: High-efficiency siRNA delivery with R8-PEI dissolvable microneedles. International Journal of Pharmaceutics. 675. 125516–125516. 1 indexed citations
2.
Li, Xi, et al.. (2025). Curcumin suppresses malignant behaviors of ovarian cancer through regulation of tumor-associated macrophages. Medical Oncology. 42(5). 151–151. 2 indexed citations
3.
Yang, Wenxiao, et al.. (2024). Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study. Cancer Medicine. 13(7). e7147–e7147. 2 indexed citations
4.
Li, Ningning, et al.. (2024). Long-Term Prognostic Analysis of Chemoradiotherapy vs. Chemotherapy after D2 Resection for High-Risk Gastric Cancer: Results from a Prospective Randomized Control Study. International Journal of Radiation Oncology*Biology*Physics. 120(2). S46–S46. 1 indexed citations
5.
Wang, Jinyan, et al.. (2022). Application of Medical-Nursing Integration Multidisciplinary-Assisted Surgical Wound Nursing Mode in Improving the Quality of Wound Treatment. Emergency Medicine International. 2022. 1–6. 1 indexed citations
6.
7.
Wang, Wei, et al.. (2022). Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer. World Journal of Clinical Cases. 10(26). 9264–9275. 1 indexed citations
8.
Lv, Jie, et al.. (2022). Serum Uric Acid to Serum Creatinine Ratio and Risk of Stroke Recurrence in Young Adults with Ischemic Stroke. Neuropsychiatric Disease and Treatment. Volume 18. 2031–2039. 11 indexed citations
9.
Lu, Ying, et al.. (2022). External Treatment With Chinese Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 13. 764473–764473. 8 indexed citations
10.
Wang, Zhe, Songsong Zhao, Jun Shi, et al.. (2021). Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: A comparative study of molecular inhibitors and siRNA therapeutics. Acta Biomaterialia. 138. 443–452. 19 indexed citations
11.
12.
Shi, Jun, Rongfen Huo, Ningli Li, et al.. (2019). CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress. BMC Cancer. 19(1). 1140–1140. 25 indexed citations
13.
Li, Leilei, et al.. (2018). Mechanisms of resistance to chemotherapy and radiotherapy in hepatocellular carcinoma. Translational Cancer Research. 7(3). 765–781. 10 indexed citations
14.
Jiao, Lijing, Ling Bi, Yan Lu, et al.. (2018). Cancer chemoprevention and therapy using chinese herbal medicine. Biological Procedures Online. 20(1). 1–1. 46 indexed citations
15.
Mong, Jamie, Jun Shi, David Chan, et al.. (2017). Single-cell combined mutation and gene expression studies of circulating tumor-associated cells in non-small cell lung cancer. Annals of Oncology. 28. v35–v35.
16.
Shi, Jun, Jamie Mong, Tan Min Chin, et al.. (2017). EGFR mutation detection in plasma cell-free DNA correlates with clinical outcomes in non-small cell lung cancer. Annals of Oncology. 28. v476–v477. 1 indexed citations
17.
Shi, Jun, et al.. (2013). The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells. OncoTargets and Therapy. 6. 1643–1643. 24 indexed citations
18.
Shi, Shuo, Yuezhen Deng, Jiang‐Sha Zhao, et al.. (2012). RACK1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway. Journal of Biological Chemistry. 287(11). 7845–7858. 76 indexed citations
19.
Barnes, Natalie Y., Jun Shi, Hiroshi Yajima, Gopal Thinakaran, & Angèle Parent. (2007). Steady‐state increase of cAMP‐response element binding protein, Rac, and PAK signaling in presenilin‐deficient neurons. Journal of Neurochemistry. 104(6). 1637–1648. 8 indexed citations
20.
Schmitt, Adam M., et al.. (2005). Wnt–Ryk signalling mediates medial–lateral retinotectal topographic mapping. Nature. 439(7072). 31–37. 227 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoyu Zhou Breakdown of academic impact, for papers by Xu Li Breakdown of academic impact, for papers by Ronghui Li Breakdown of academic impact, for papers by Peter G. Miller Breakdown of academic impact, for papers by Wenxiang Wang Breakdown of academic impact, for papers by Jufang Huang Breakdown of academic impact, for papers by Linyi Chen Breakdown of academic impact, for papers by Xue Wu Breakdown of academic impact, for papers by Dandan Hu Breakdown of academic impact, for papers by Haitao Zhu
Rankless by CCL
2026